BIOLASE (BIOL) Stock Price, News & Analysis

Company Overview

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.

Key Stats

• Today's Range: N/A
• 50-Day Range: $0.0010 to $0.0125
• 52-Week Range: N/A
• Volume: 6 shs
• Average Volume: 2.58 million shs
• Market Capitalization: $581 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $0.40
• Consensus Rating: Buy

BIOL Stock Analysis - Frequently Asked Questions

How were BIOLASE's earnings last quarter?

BIOLASE, Inc. (NASDAQ:BIOL) announced its quarterly earnings data on Wednesday, November, 10th. The medical technology company reported ($50.00) earnings per share (EPS) for the quarter, beating the consensus estimate of ($75.00) by $25.00. The medical technology company had revenue of $9.53 million for the quarter. BIOLASE had a negative trailing twelve-month return on equity of 1,782.73% and a negative net margin of 41.65%.

When did BIOLASE's stock split?

Shares of BIOLASE reverse split on Friday, July 28th 2023.The 1-100 reverse split was announced on Friday, July 28th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, July 28th 2023. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

How do I buy shares of BIOLASE?

Shares of BIOL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of BIOLASE own?

Based on aggregate information from My MarketBeat watchlists, some other companies that BIOLASE investors own include Bionano Genomics (BNGO), Tonix Pharmaceuticals (TNXP), SNDL (SNDL), Zomedica (ZOM), NIO (NIO), Exela Technologies (XELA) and Ocugen (OCGN).

Company Calendar

• Last Earnings: 11/10/2021
• Today: 9/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Dental equipment & supplies
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:BIOL
• Previous Symbol: NASDAQ:BLTI
• CIK: 811240
• Web: www.biolase.com
• Phone: (949) 361-1200
• Fax: 949-273-6677
• Employees: 160
• Year Founded: 1987

Price Target and Rating

• Average Price Target for BIOLASE: $0.40
• High Price Target: $0.40
• Low Price Target: $0.40
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): ($14.94)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$20.63 million
• Net Margins: -41.65%
• Pretax Margin: -41.56%
• Return on Equity: -1,782.73%
• Return on Assets: -55.31%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.71
• Quick Ratio: 0.36

Sales & Book Value

• Annual Sales: $48.83 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.07) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 33,407,000
• Free Float: 33,317,000
• Market Cap: $581 thousand
• Optionable: Not Optionable
• Beta: 0.67